Dedicated to a Safer World
Dedicated to developing novel medical solutions to protect Americans at home and on the battlefield.
April 26, 2017
PharmAthene and Altimmune Announce Combined Company Approved for Trading on Nasdaq...
March 28, 2017
Altimmune Receives $7.3 Million Contract Modification from BARDA to Fund Manufactu...
March 14, 2017
PharmAthene Reports Year-End 2016 Financial and Operational Results
March 13, 2017
PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockho...